Contact this trialFirst, we need to learn more about you.
TPN-101 for Amyotrophic Lateral Sclerosis
Recruiting0 awardsPhase 2
Orange, California
This trial tests a new drug, TPN-101, for safety and tolerability in patients with ALS and/or FTD who have a specific genetic mutation. The goal is to see if it can help manage symptoms or slow disease progression.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service